Growth Stocks To Consider - September 28th

Key Points

• The five growth stocks highlighted are Prologis, Teledyne Technologies, Ascendis Pharma A/S, Acadia Realty Trust, and Hamilton Lane, chosen for their high trading volumes recently.
• Prologis operates in logistics real estate, managing about 1.2 billion square feet across 19 countries as of March 2024.
• Ascendis Pharma A/S focuses on developing therapies for unmet medical needs, including treatments for growth hormone deficiency.

Prologis, Teledyne Technologies, Ascendis Pharma A/S, Acadia Realty Trust, and Hamilton Lane are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies whose revenues and earnings are expected to expand at an above‐average rate compared with the broader market. Investors buy them primarily for capital appreciation rather than dividend income, often accepting higher price‐to‐earnings ratios in anticipation of future growth. Because their valuations hinge on strong performance forecasts, growth stocks can be more volatile if those expectations change. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Prologis (PLD)

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.

Read Our Latest Research Report on PLD

Teledyne Technologies (TDY)

Teledyne Technologies Incorporated, together with its subsidiaries, provides enabling technologies for industrial growth markets in the United States and internationally. Its Digital Imaging segment provides visible spectrum sensors and digital cameras; and infrared, ultraviolet, visible, and X-ray spectra; as well as micro electromechanical systems and semiconductors, including analog-to-digital and digital-to-analog converters.

Read Our Latest Research Report on TDY

Ascendis Pharma A/S (ASND)

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.

Read Our Latest Research Report on ASND

Acadia Realty Trust (AKR)

Read Our Latest Research Report on AKR

Hamilton Lane (HLNE)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

Read Our Latest Research Report on HLNE